Latest Ratios: P/E Ratio 60.8x · EV/EBITDA 5.9x · ROE 10.7%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $143M | $433M | $465M | $324M | $407M | $3.2B | $4.1B | — | — |
| Enterprise Value | $526M | $816M | $1.1B | $973M | $1.0B | $3.4B | $4.1B | — | — |
| P/E Ratio → | 60.78 | 178.95 | — | — | — | 25.68 | 51.69 | — | — |
| P/S Ratio | 0.09 | 0.28 | 0.35 | 0.32 | 0.53 | 3.43 | 7.76 | — | — |
| P/B Ratio | 0.26 | 0.75 | 1.47 | 0.93 | 1.04 | 4.78 | 7.53 | — | — |
| P/FCF | — | — | 130.28 | — | — | — | — | — | — |
| P/OCF | — | — | 30.53 | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.53 | 0.86 | 0.97 | 1.32 | 3.66 | 7.65 | — | — |
| EV / EBITDA | 5.91 | 9.18 | 12.69 | 24.65 | — | 16.35 | 29.33 | — | — |
| EV / EBIT | 7.68 | 6.38 | 17.62 | 84.86 | — | 18.19 | 31.51 | — | — |
| EV / FCF | — | — | 318.30 | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.7% | 38.7% | 45.2% | 47.4% | 40.4% | 70.9% | 68.4% | 69.1% | 64.3% |
| Operating Margin | 4.5% | 4.5% | 4.9% | 1.2% | -45.3% | 20.7% | 24.6% | 28.5% | 18.5% |
| Net Profit Margin | 3.1% | 3.1% | -2.6% | -5.8% | -38.9% | 13.4% | 15.0% | 21.5% | 14.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.7% | 10.7% | -10.3% | -15.9% | -56.2% | 20.6% | 19.7% | 32.2% | 18.6% |
| ROA | 3.9% | 3.9% | -2.8% | -4.7% | -21.9% | 9.8% | 10.4% | 20.6% | 11.7% |
| ROIC | 5.3% | 5.3% | 4.9% | 0.9% | -27.6% | 21.0% | 25.1% | 29.2% | 15.7% |
| ROCE | 6.7% | 6.7% | 6.1% | 1.0% | -27.8% | 16.4% | 18.5% | 29.8% | 15.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.72 | 0.72 | 2.25 | 2.11 | 1.91 | 0.76 | 0.57 | 0.10 | 0.11 |
| Debt / EBITDA | 4.68 | 4.68 | 7.97 | 18.54 | — | 2.42 | 2.26 | 0.25 | 0.43 |
| Net Debt / Equity | — | 0.67 | 2.12 | 1.87 | 1.54 | 0.33 | -0.10 | 0.10 | 0.10 |
| Net Debt / EBITDA | 4.31 | 4.31 | 7.50 | 16.44 | — | 1.05 | -0.41 | 0.25 | 0.40 |
| Debt / FCF | — | — | 188.02 | — | — | — | — | — | — |
| Interest Coverage | 1.61 | 1.61 | 0.69 | 0.14 | -7.94 | 6.39 | 5.23 | 58.00 | 45.69 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.60 | 1.60 | 1.91 | 2.65 | 3.55 | 4.44 | 5.36 | 3.10 | 3.44 |
| Quick Ratio | 1.60 | 1.60 | 1.86 | 2.61 | 3.50 | 4.44 | 5.36 | 3.10 | 3.44 |
| Cash Ratio | 0.15 | 0.15 | 0.24 | 0.61 | 1.24 | 2.63 | 3.85 | 0.02 | 0.04 |
| Asset Turnover | — | 1.22 | 1.11 | 0.82 | 0.59 | 0.65 | 0.47 | 0.83 | 0.79 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | 6.7% | — | — |
| Payout Ratio | — | — | — | — | — | — | 346.0% | 2.7% | 5.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.6% | 0.6% | — | — | — | 3.9% | 1.9% | — | — |
| FCF Yield | — | — | 0.8% | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 6.7% | — | — |
| Shares Outstanding | — | $182M | $169M | $166M | $164M | $166M | $162M | $162M | $138M |
CMS Regulatory Marketing Compliance
Based on reported figures, SelectQuote trades at a P/B of 0.27, which suggests the market heavily discounts the firm's book value due to the inherent volatility of its LTV-based revenue recognition model and the ongoing regulatory pressures facing the Medicare Advantage distribution sector.
The current P/B multiple appears to reflect significant investor skepticism regarding the quality of the firm's assets, particularly the contract assets derived from estimated future commissions. This valuation level suggests that the market is pricing in a high probability of future downward revisions to these estimates rather than rewarding the firm for its recent deleveraging efforts.
As reported in quarterly financial data, the combined ratio has fluctuated between 85.3% and 112.4% over the last ten quarters, indicating that the firm's underwriting profitability remains highly sensitive to seasonal enrollment cycles and the rising costs of customer acquisition within the competitive Medicare landscape.
The wide variance in the combined ratio suggests that SelectQuote struggles to maintain consistent underwriting margins, as the expense ratio often spikes during periods of intense marketing competition. Investors should monitor whether the firm can stabilize these ratios as it attempts to integrate pharmacy services to improve long-term policy retention.
According to recent financial statements, the firm has successfully reduced its D/E ratio from a peak of 2.63 in 2025Q1 to 0.61 in 2026Q3, signaling a significant improvement in the company's capital structure and a reduced reliance on debt to fund its aggressive growth strategy.
This shift toward a more conservative capital structure appears to provide the firm with greater strategic flexibility to navigate regulatory headwinds. However, the low cash position relative to historical marketing spend requirements warrants further investigation into whether the current leverage profile is sufficient to support future growth initiatives.
As indicated by historical financial data, the return on equity (ROE) is a frequently misapplied metric for SelectQuote, as it is heavily distorted by non-cash revenue recognition under ASC 606 and does not accurately reflect the firm's actual cash-generating capacity or underlying operational risk.
Investors should prioritize cash flow from operations and adjustments for LTV revisions over ROE, as the latter can be artificially inflated by optimistic future commission estimates. Relying on ROE obscures the reality that the firm's profitability is often tied to accounting assumptions rather than realized cash inflows.
Includes 30+ ratios · 8 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SLQT stock.
SelectQuote, Inc.'s current P/E ratio is 60.8x. The historical average is 85.4x. This places it at the 67th percentile of its historical range.
SelectQuote, Inc.'s current EV/EBITDA is 5.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 18.4x.
SelectQuote, Inc.'s return on equity (ROE) is 10.7%. The historical average is 2.4%.
Based on historical data, SelectQuote, Inc. is trading at a P/E of 60.8x. This is at the 67th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
SelectQuote, Inc. has 38.7% gross margin and 4.5% operating margin.
SelectQuote, Inc.'s Debt/EBITDA ratio is 4.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.